Stock Analysis
GSK plc American Depositary Shares (Each representing two Ordinary Shares)GSK
Sector: Healthcare · Industry: Drug Manufacturers - General
AnalystsHold32 analystsPrice is 35% of the way from the year's low to its high.
PMP Verdict
Insufficient financial data
No financial statements on file for this ticker — fundamental scores are not computed.
Bull Case
- ✓ROE 28.4% — efficient capital deployment
- ✓Interest coverage 12.0× — debt well covered
What's happening with GSK
About GSK plc American Depositary Shares (Each representing two Ordinary Shares)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. Show more
The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Employees: 66,841 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
Valuation
50CP/E (TTM)—
Price / TTM EPS (own statements)
P/FCF13.6xA
Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield7.3%A
Grade A: ValueInverse of Finnhub P/FCF (own TTM FCF unavailable)
P/S (TTM)2.19xB
Grade B: FairPrice / TTM Revenue (own statements)
EV/EBITDA13.4xB
Grade B: FairEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales2.6xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E10.1xA
Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio4.54xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.96D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield3.66%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio55.3%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
40D+ROIC—
NOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE28.4%A
Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks
ROA7.8%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin14.5%A
Grade A: HighNet Income / Revenue
Operating Margin—
TTM EBIT / TTM Revenue
Gross Margin73.6%A
Grade A: PremiumGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
0ERevenue CAGR—
Compound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth—
Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income—
Stock-based comp/Net income. >30% = dilution risk
SBC / Revenue—
TTM stock-based comp / TTM Revenue
Financial Health
31DAltman Z-Score—
Bankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.82xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.52xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage12.0xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity1.03xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Quality
0EPiotroski F-Score—
Financial strength 0–9. >7 Strong
Beneish M-Score—
Earnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability—
EBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.54xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
0EROIC >12% Years—
Share of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)—
Median annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years—
Share of completed fiscal years with positive free cash flow
Net Margin Floor—
Weakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)—
TTM net income per share (Finnhub fallback)
Cash / Share$0.76
Cash & short-term investments per share (Finnhub)
Book Value / Share$4.33
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.—
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity—
Shareholders' equity (book value)
Asset / Liability—
Total Assets / Total Liabilities
Market
Market Cap$99.19B
Current Market Capitalization
Beta1.21C
Grade C: VolatilePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Ratio snapshot Oct 16, 2026
Key Insights: GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
GSK is up 1.00% at the last close. Return on equity of 28.4% is well above the market average.
- The stock currently yields 3.7% in dividends.
See how GSK ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all GSK moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 15 | Pre-market | 49.14 | +2.65% | 2.09 |
| Oct 15 | Regular | 49.27 | +2.92% | 2.28 |
| Oct 14 | Regular | 47.89 | +3.49% | 3.26 |
| Oct 14 | After-hours | 47.76 | +3.22% | 3.04 |
Frequently Asked Questions about GSK
What is the current GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) stock price?
GSK is trading at $49.51 at the last market close, up 1.00% on the session. PreMarketPrice tracks GSK pre-market, intraday and after-hours prices.
Is GSK stock a buy right now?
PreMarketPrice's quantitative model rates GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s financial health at 31/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is GSK stock overvalued?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) trades at a trailing P/E of n/a and our valuation score rates it 50/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does GSK plc American Depositary Shares (Each representing two Ordinary Shares) report earnings?
No confirmed earnings date is currently scheduled for GSK. The Earnings section lists recent reports and updates as dates are announced.
What sector does GSK plc American Depositary Shares (Each representing two Ordinary Shares) operate in?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) operates in the Healthcare sector, within the Drug Manufacturers - General industry. The Related Stocks section lists sector peers for comparison.
What does GSK plc American Depositary Shares (Each representing two Ordinary Shares) do?
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales.
About GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Stock
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) is a US-listed stock operating in the Healthcare sector, specifically the Drug Manufacturers - General industry. As of the latest update, GSK plc American Depositary Shares (Each representing two Ordinary Shares) is trading at $49.51, up 1.00% on the day with a market capitalization of $99.2 billion. The financial health score for GSK is 31/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for GSK stock.
GSK Stock Analysis & Key Metrics
On PreMarketPrice, you can track GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) across multiple dimensions:
- Pre-market price & movement: Real-time GSK stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for GSK with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for GSK plc American Depositary Shares (Each representing two Ordinary Shares) across multiple reporting periods.
- Financial health score: A composite score of 31/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for GSK.
- Sector peers: Compare GSK against 4 other healthcare stocks on key financial metrics.
Is GSK a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) as an investment. The financial health score of 31/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.